Other languages Nova Eye Medical Limited

Equities

EYE

AU0000094252

Market Closed - Australian S.E. Other stock markets 02:10:52 2024-04-24 am EDT			5-day change	1st Jan Change
0.27 ^AUD	+1.89%		+8.00%	+12.50%

Mar. 15	Nova Eye Medical Completes Retail Entitlement Offer	MT
Feb. 22	Nova Eye Medical Limited Reports Earnings Results for the Half Year Ended December 31, 2023	CI

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Nova Eye Medical Completes Retail Entitlement Offer	Mar. 14
Nova Eye Medical Limited Reports Earnings Results for the Half Year Ended December 31, 2023	Feb. 22
Nova Eye Medical Completes Placement, Institutional Entitlement Offer; Shares Plunge 22%	Feb. 13
Nova Eye Medical's US Sales of Glaucoma Surgical Devices Surge in H2 2023; Shares Jump 13%	Jan. 07
Lower Oil, Metal Prices Pull Down Australian Shares	Dec. 29
Nova Eye Medical Jumps 37% After Withdrawal of Proposed Changes in US Medicare Coverage	Dec. 28
Nova Eye Medical Announces Deferral of Proposed US Medicare Changes; Shares Jump 13%	Dec. 07
Nova Eye Medical Limited Reports Earnings Results for the Full Year Ended June 30, 2023	23-08-27
Nova Eye Medical's Glaucoma Surgical Devices Sales in the US Hits $2.2 Million in Three Months to July; Shares Jump 8%	23-08-01
US FDA Approves Nova Eye Medical's Canaloplasty Device for Glaucoma Surgery for US Launch; Shares Jump 20%	23-03-30
Nova Eye Medical Limited Reports Earnings Results for the Half Year Ended December 31, 2022	23-02-28
Nova Eye Medical Limited Announces New, Additional Clinical Application for 2RT Currently Under Investigation	23-01-24
Nova Eye Medical Limited Appoints Daniel Webb as Director	22-11-16
International Researchers Join in Nova Eye Medical’s Study on Eye Laser Therapy	22-10-25
Nova Eye Medical Limited Completes Initial Recruitment of Investigator Sites	22-10-23
Nova Eye Medical Limited Reports Earnings Results for the Full Year Ended June 30, 2022	22-08-25
Nova Eye Medical Expects 0.5% Uptick in FY22 Sales of Glaucoma Surgical Devices Segment	22-07-08
Nova Eye Medical Starts Commercial Roll-out of Canaloplasty Device in Europe, Asia Pacific; Shares Jump 5%	22-06-07
Nova Eye Medical Limited Announces the Commencement of the Commercial Roll-Out of its Next Generation Canaloplasty Device, iTrack Advance, in Select Markets in Europe and the Asia Pacific	22-06-07
Nova Eye Medical Limited Announces Regulatory Pathway for AlphaRET 2RT in the USA	22-05-02

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Nova Eye Medical Limited

Equities

EYE

AU0000094252

Other languages

Filters